Qingsong Guo

Dr. Qingsong Guo


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
HLHua yu Lu
Hua yu Lu
JLJingjing Lu
Jingjing Lu
XLXiaohong Li
Xiaohong Li
HZHui Zhu
Hui Zhu
XFXiangjun Fan
Xiangjun Fan
ZWZhiwei Wang
Zhiwei Wang
Background: Pancreatic cancer is one of the most aggressive cancers, and the aggressiveness of pancreatic cancer is in part due to its intrinsic and extrinsic drug resistance characteristics, which are also associated with the acquisition of epithelial-to-mesenchymal transition (EMT). Increasing evidence suggests that EMT-type cells share many biological characteristics with cancer stem-like cells. And miR-200 has been identified as a powerful regulator of EMT. Methods: Cancer Stem Cells (CSCs) of human pancreatic cancer cell line PANC-1 were processed for CD24, CD44 and ESA multi-colorstaining, and sorted out on a BD FACS Aria II machine. RT-qPCR was performed using the miScript PCR Kit to assay the expression of miR-200 family. In order to find the role of miR-200a in the process of EMT, miR-200a mimic was transfected to CSCs. Results: Pancreatic cancer cells with EMT phenotype displayed stem-like cell features characterized by the expression of cell surface markers CD24, CD44 and epithelial-specific antigen (ESA), which was associated with decreased expression of miR-200a. Moreover, overexpression of miR-200a was resulted in down-regulation of N-cadherin, ZEB1 and vimentin, but up-regulation of E-cadherin. In addition, miR-200a overexpression inhibited cell migration and invasion in CSCs. Conclusion: In our study, we found that miR-200a played an important role in linking the characteristics of cancer stem-like cells with EMT-like cell signatures in pancreatic cancer. Selective elimination of cancer stem-like cells by reversing the EMT phenotype to mesenchymal-to-epithelial transition (MET) phenotype using novel agents would be useful for prevention and/or treatment of pancreatic cancer.

31 October 2022 in Biomaterials
Verified
Journal Article
Closed access
YHYan Huang
Yan Huang
YXYang Xu
Yang Xu
JZJiachen Zhu
Jiachen Zhu
JWJian Wan
Jian Wan
YXYicheng Xiong
Yicheng Xiong
YYYumin Yang
Yumin Yang

10 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
JLJia Luo
Jia Luo
ZGZongyu Guan
Zongyu Guan
WGWeijie Gao
Weijie Gao
CWChen Wang
Chen Wang
ZXZhongyuan Xu
Zhongyuan Xu
YLYong Ling
Yong Ling
Theranostic agents for concurrent cancer therapy and diagnosis have begun attracting attention as a promising modality. However, accurate imaging and identification remains a great challenge for theranostic agents. Here, we designed and synthesized a novel theranostic agent H6M based on the “double-locked” strategy by introducing an electron-withdrawing nitro group into 1-position of a pH-responsive 3-amino-β-carboline and further covalently linking the hydroxamic acid group, a zinc-binding group (ZBG), to the 3-position of β-carboline to obtain histone deacetylase (HDAC) inhibitory effect for combined HDAC-targeted therapy. We found that H6M can be specifically reduced under overexpressed nitroreductase (NTR) to produce H6AQ, which emits bright fluorescence at low pH. Notably, H6M demonstrated a selective fluorescence imaging via successive reactions with NTR (first “key”) and pH (second “key”), and precisely identified tumor margins with a high S/N ratio to guide tumor resection. Finally, H6M exerted robust HDAC1/cancer cell inhibitory activities compared with a known HDAC inhibitor SAHA. Therefore, the NTR/pH-activated theranostic agent provided a novel tool for precise diagnosis and efficient tumor therapy.

27 February 2025 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
JWJian Wan
Jian Wan
YXYang Xu
Yang Xu
TQTianmu Qi
Tianmu Qi
XXXiaoxia Xue
Xiaoxia Xue
YLYuxi Li
Yuxi Li
YHYan Huang
Yan Huang
Patient specific induced pluripotent stem cells (iPSCs) derived β cells represent an effective means for disease modeling and autologous diabetes cell replacement therapy. In this study, an AG73-5%gelatin methacryloyl (GelMA) /2% alginate methacrylate (AlgMA) hydrogel was employed to generate pancreatic progenitor (PP) organoids and improve stem cell-derived β (SC-β) cell differentiation protocol. The laminin-derived homolog AG73, which mimics certain cell‒matrix interactions, facilitates AKT signaling pathway activation to promote PDX1+/NKX6.1+ PP organoid formation and effectively modulates subsequent epithelial–mesenchymal transition (EMT) in the endocrine lineage. The 5%GelMA/2%AlgMA hydrogel mimics the physiological stiffness of the pancreas, providing the optimal mechanical stress and spatial structure for PP organoid differentiation. The Syndecan-4 (SDC4)-ITGAV complex plays a pivotal role in the early stages of pancreatic development by facilitating the formation of SOX9+/PDX1+ bipotent PPs. Our findings demonstrate that AG73-GelMA/AlgMA hydrogel-derived SC-β cells exhibit enhanced insulin secretion and accelerated hyperglycemia reversal in vivo. This study presents a cost-effective, stable, and efficient alternative for the comprehensive 3D culture of SC-β cells in vitro by mitigating the uncertainties associated with conventional culture methods.

30 September 2025 in Annals of Hepato-Biliary-Pancreatic Surgery
Verified
Journal Article
Open access
PDF file
QGQingsong Guo
Qingsong Guo
JWJian Wan
Jian Wan
YHYan Huang
Yan Huang
DWDongzhi Wang
Dongzhi Wang
QCQiyang Chen
Qiyang Chen
YLYuhua Lu
Yuhua Lu
Qingsong Guo, Jian Wan, Yan Huang, Dongzhi Wang, Qiyang Chen, Chenhao Wu, Xiangjun Fan, Peng Wang, Yuhua Lu. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.25-123

3 June 2024 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
LWLin Wang
Lin Wang
JWJian Wan
Jian Wan
YXYang Xu
Yang Xu
YHYan Huang
Yan Huang
DWDongzhi Wang
Dongzhi Wang
QGQingsong Guo
Qingsong Guo